Fig. 4
From: Mast cell marker gene signature in head and neck squamous cell carcinoma
Predictive effects of the mast cell gene signature (MCS) risk score and clinicopathological variables on the prognosis of overall survival of patients with head and neck squamous cell carcinoma. Univariate and multivariate Cox regression analyses between clinicopathological variables (including the MCS risk score) and overall survival of patients in the training (A, B), testing (D, E), and the entire “The Cancer Genome Atlas” (G, H) cohorts; green and red squares represent univariate and multivariate analysis, respectively. Comparison of area under the receiver operating characteristic curve between clinicopathological variables and MCS risk score in the training, testing, and the entire “The Cancer Genome Atlas” cohorts (C, F, I, respectively)